Geron Corp
GERN Real Time Price USDRecent trades of GERN by members of U.S. Congress
No Congress Trading data for this ticker
Congress Trading Dashboard
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
---|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
---|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
---|
Recently reported changes by institutional investors
Quarterly net insider trading by GERN's directors and management
Government lobbying spending instances
-
$20,000 Oct 21, 2024 Issue: Health Issues
-
$30,000 Jul 21, 2024 Issue: Health Issues
-
$30,000 Apr 22, 2024 Issue: Health Issues
-
$30,000 Jan 22, 2024 Issue: Health Issues
-
$10,000 Oct 19, 2023 Issue: Health Issues
Estimated quarterly lobbying spending
New patents grants
No new patents for this ticker
U.S. Patents DashboardFederal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of GERN in WallStreetBets Daily Discussion
Recent insights relating to GERN
Recent picks made for GERN stock on CNBC
ETFs with the largest estimated holdings in GERN
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view GERN Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.